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Introduction
Patients with atrial fibrillation are at increased risk of
stroke. Although anticoagulation with warfarin reduces
this risk considerably, it is not widely prescribed to
this at-risk group of patients.1,2 Warfarin is a potentially
dangerous drug as it has a narrow therapeutic index:
give too much and patients are at risk of haemorrhage,
give too little and it offers little protection from
thrombosis. Warfarin is monitored using an inter-
national normalised ratio (INR) to measure the degree
of anticoagulation.3 Dosage prediction programmes
for warfarin have been in existence for some time, with
the first computer models based on hospital doctors’
decisions.4,5 More recently, a wider range of approaches
have been used to develop more sophisticated com-
puterised decision support systems (CDSS).
Refereed papers
Lessons from the implementation of a near
patient anticoagulant monitoring service 
in primary care
Simon de Lusignan MSc MRCGP
Senior Lecturer, Primary Care Informatics
Andrew Singleton BSc MBA MSc
Non-clinical Scientist
Sally Wells RGN
Research Nurse, Primary Care Informatics
Department of Community Health Sciences, St George’s Hospital Medical School, London, UK
ABSTRACT
Objective To evaluate the implementation of a
primary care, nurse-led, near patient anticoagulant
monitoring service.
Design Action research workshops, supported 
by questionnaires and clinical audit, to define the
strengths and weaknesses of the service and the
effectiveness of the computerised decision support
system used to set the dosage of anticoagulant and
time interval to the next appointment.
Setting 13 general practices that implemented
anticoagulant monitoring in a primary care organ-
isation in south east England.
Participants 18 practice nurses, 72% of whom had
over 20 years’ clinical experience; the university-
based investigators and managers from the primary
care organisation.
Main outcome measure The nurses felt that the
patients preferred the practice-based service, finding
it more personal and accessible. However, circum-
stances arose where the nurse’s intuition had to
override the software’s advice. The nurses found 
it stressful when they were unclear whether their
decision making represented acceptable variation
or dangerous practice. An audit tool was developed
to measure the extent to which there was variation
from the software’s recommendation, and patterns
of variation emerged. Most evident was that nurses
responded to uncertainty by practising cautiously,
shortening the interval until the next visit and slightly
reducing the recommended dose of warfarin.
Conclusions The group, by sharing their experi-
ences through a structured series of workshops,
developed an understanding of when it might be
appropriate to vary from the decision support soft-
ware’s recommendations and how this could be
audited. The technological solution modelled on hos-
pital practice proved hard to implement in primary care.
Keywords (MeSH terms): anticoagulants, computer-
assisted, decision making, family practice, medical
informatics, medical informatics applications,
warfarin
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Near patient testing allows monitoring to be
provided outside the hospital setting. Traditionally
patients had to travel to the local hospital for testing,
where junior doctors adjusted their warfarin dose
without the benefit of CDSS.6,7 The combination of
near patient testing and CDSS allows warfarin testing
to take place in local clinics or in patients’ homes, with
the service provided by nurses or other non-medical
staff. Where comparison has been made between nurses
using computerised decision support and junior
doctors using clinical judgement, the nurses achieved
better control for patients with an INR target ratio of
2–3, and as good control as the doctors when target
INR is 3–4.5.8
A primary care organisation (PCO) recognised the
potential benefits of a practice-based anticoagulation
service and implemented it across 13 practices, deciding
that practice nurses would be the appropriate profes-
sional group to deliver the service. They put on a
training course comprising the relevant biomedicine:
how anticoagulants work, the patients who need it
and for how long, interactions and safety issues. The
practice nurses also received training on the near patient
testing device (Coagucheck – Roche Diagnostics), the
CDSS (Eider software) and in quality assurance.9–11
They were advised that the dose generated by the
CDSS was a suggestion, but there had to be good
reason not to follow it. The nurses were also required
to identify a general practitioner (GP) who would
provide them with day-to-day support. Despite these
careful preparations, the implementation did not go
entirely smoothly and the nurses running the clinics
found them stressful. Against this backdrop, the
authors were commissioned by the PCO to evaluate
the clinics and identify what the problems were. The
action research adopted is described in this paper.
Method
Action research is a problem-solving intervention,
involving the researchers as well as the subjects of the
study in actively looking for ways to overcome obstacles.
Its approach is systematic, involving problem definition,
reflection and learning, and the design of action inter-
ventions to overcome the barrier or barriers identified.12
Action research was an appropriate research method
as it would allow two of the research team to use their
local knowledge and experience fully in the investigation.
SW had been involved in near patient anticoagulant
clinics for over five years in one practice, and had been
mentor to many of the nurses offering this service;
and S de L is a part-time GP in the locality.
We looked for relevant background information
prior to establishing a timetable for the action
research. We searched Medline for information about
atrial fibrillation and stroke, use of anticoagulants and
near patient testing. We read PCO board minutes, the
training course timetable and any documents relat-
ing to the implementation of the clinics available from
the PCO or practices. We contacted PCO managers
and lead clinicians involved and gave them the oppor-
tunity to submit any materials. So we could search
these materials more effectively and group them into
emergent themes, we imported them into qualitative
research software (N’VIVO – QSR version 1.2).
Workshops, questionnaires and clinical audit were
chosen as the principal elements of the research
process. We designated the workshop as the primary
source of information gathering. We decided to do
this as we wanted the nurses to be the centre of the
investigation as they were likely to have good oral
communication skills. Questionnaires were used 
to confirm the findings of the workshops and, if
appropriate, one or more clinical audits were carried
out to check whether any issues about practice were
supported by clinical data.
The workshops were a combination of plenary
discussions and work in pairs or small groups. Field
notes were taken of the discussions by one of the
research team, any flipchart lists were retained and
each nurse completed a workbook of their discus-
sions which was handed in at the end of the session.
Consensus established in the discussion reported back
to all the nurses in questionnaire form with the results
of the questionnaires used to verify findings.
Participants were invited to share their experiences
openly and honestly. We emphasised confidentiality
and anonymity within the group. Ground rules for
feedback stressed the importance of valuing all
contributions. Questions were designed to elicit both
positive and negative features of running anticoagulant
clinics.
We elected to timetable three workshops, and 
all the nurses involved in the clinic were invited to
each of the workshops regardless of whether they had
attended a previous session or not. The aim of the first
was to identify the benefits the clinics had offered and
lessons learned. The second would explore the prin-
cipal barriers to implementing the clinics and ways to
overcome them. The final workshop would hand over
the learning from the evaluation and explore whether
the group wished to go on meeting.
Results
The 18 practice nurses who ran the clinics were very
experienced. Nearly three-quarters of them had more
than 20 years’ nursing experience, and 67% had over
10 years’ experience of working in primary care.
Eighty-three percent had been running anticoagulant
clinics for between six and 12 months. Most of the
nurses saw more than ten patients per week, and had
appointment times of between six and ten minutes.
All 18 nurses attended the first workshop. The field
notes on the consensus discussions, the workbooks
and flipcharts all indicated that the nurses had had
very positive comments from patients about the
practice-based clinics:
Patients really like attending the surgery. (Nurse H) 
The patient knows the results straight away. (Nurse F) 
Patients prefer the clinics – more convenient, less waiting
time. (Nurse I)
However, there were a number of concerns about the
equipment and the CDSS. All three small groups
listed problems with inflexibility within the software
in the real clinical situations in which the nurses found
themselves. The study team noted that over a number
of specific issues knowledge was being exchanged
between participants, and problems for one nurse
were solved by another (for example, how to deal with
a patient who was taking different warfarin doses on
alternate days).
A post-workshop questionnaire asked nurses to
rate a number of statements from 1 (strongly disagree)
to 5 (strongly agree). There was good agreement with
statements about the benefits of general practice-based
clinics, but negative themes emerged in the discus-
sions and on the flipcharts about uncertainty with the
software and about quality control procedures (see
Table 1).
The second workshop was attended by 12 nurses.
The nurses displayed anger and frustration with the
software. They often experienced cognitive dissonance
when the software was advising one thing and their
clinical experience was suggesting that they should do
another. In these circumstances they turned to the
lead GP within their practice, who usually agreed with
their clinical judgement. None were aware of any of
their patients having had a major bleed as a result of
over-treatment or thrombosis as a result of under-
treatment. At that stage the clinics had treated 
792 patients (0.71% of a locality population of
107 296 patients).
We devised an audit tool to measure the extent 
to which the nurses varied from the CDSS advice 
(see Figure 1). This entailed completing a simple audit
form between workshops two and three. Treatment of
15 patients attending the clinic were recorded. Their
reason for taking warfarin, age and sex were recorded,
along with any variation in warfarin dose or interval
to the next appointment. Eleven nurses completed the
audit, providing a sample of 165 patient encounters.
Nurses were very cautious, hardly ever giving more
warfarin than recommended, but showed much more
flexibility in arranging follow-up dates than the CDSS
recommended (see Figures 2 and 3). Nurses hardly
ever recommended the patient take an increased dose
of warfarin; this only took place in 5.5% (9/165) cases.
The two doses that were 3 mg over that recommended
were given to patients who were being started on
warfarin. Thirty-four percent (56/165) of patients
were given a lower dose than recommended by the
CDSS. Twenty-one percent of patients (35/165) were
given follow-up appointments further ahead than
recommended by the CDSS, and 24% (40/165) sooner.
Most of these were a week either side of that recom-
mended. No association could be found between the
INR target range and dose alteration.
Exceeding the dose recommended was generally
done for difficult-to-control patients when their 
INR fell to well below their target range. Reduction in
dose often reflected the nurses’ intuition and cautious
approach. The follow-up date was changed to fit in
with patient holidays and other commitments. It 
was sometimes done to fit in with patient or nurse
concerns.
Eight nurses attended the final workshop. This
examined the results of the audit. The nurses reflected
on the pattern of variation and how it represented their
attempt to balance safety with lifestyle. For example,
an elderly patient, where there may be doubts about
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Table 1 Average Likert scores for post-workshop questionnaire statements
Positive themes Negative themes
Patient satisfaction 4.80 Perceived software problems 3.66
Patients prefer primary care service 4.50 Uncertain about quality control 3.53
Improved compliance 4.59
Nurse satisfaction 3.91
Scale 1–5: strongly disagree = 1, strongly agree = 5
S de Lusignan, A Singleton and S Wells30
Fi
g
u
re
 1
A
u
d
it
 t
o
o
l 
to
 m
ea
su
re
 t
h
e 
va
ri
at
io
n
 f
ro
m
 t
h
e 
ad
vi
ce
 g
iv
en
 b
y 
th
e 
C
D
SS
D
o
se
 o
f
D
o
se
 c
h
an
ge
d
 b
y 
(a
m
ou
n
t 
R
ec
al
l 
N
o.
w
ee
ks
 r
ec
al
l
A
bo
u
t 
th
e 
p
at
ie
n
t 
an
d
R
ea
so
n
 f
or
 v
ar
ia
ti
on
w
ar
fa
ri
n
  
in
 m
g)
:
in
te
rv
al
 
ch
an
ge
d 
by
:
th
ei
r 
in
d
ic
at
io
n
 +
 t
ar
ge
t
(p
le
as
e 
st
at
e 
th
e 
re
as
on
is
su
ed
   
 
O
n
ly
 c
om
pl
et
e 
if
gi
vi
ng
co
m
p
ar
ed
O
n
ly
 c
om
pl
et
e
ra
n
ge
w
he
n
 e
it
h
er
 t
h
e 
d
os
e 
or
co
m
p
ar
ed
a 
D
IF
FE
R
E
N
T
 D
O
SE
 f
ro
m
w
it
h
 t
h
at
if
gi
vi
n
g 
th
e 
re
ca
ll 
in
te
rv
al
 is
 n
ot
 t
h
e
w
it
h
 t
h
at
th
at
 r
ec
om
m
en
de
d
re
co
m
m
en
d
ed
a 
D
IF
FE
R
E
N
T
sa
m
e 
as
 t
h
at
 s
u
gg
es
te
d
re
co
m
m
en
d
ed
by
 C
D
SS
by
 C
D
SS
R
E
C
A
LL
by
 t
h
e 
d
ec
is
io
n
 s
u
p
po
rt
by
 C
D
SS
fr
om
 t
ha
t
so
ft
w
ar
e)
re
co
m
m
en
de
d
O
n
ly
 c
om
pl
et
e 
th
is
 w
he
n
N
O
T
 f
ol
lo
w
in
g 
C
D
SS
 g
u
id
an
ce
P
le
as
e 
ad
d 
fu
rt
he
r 
co
m
m
en
ts
 o
ve
rl
ea
f
or
 o
n
 
an
ot
he
r 
pi
ec
e 
of
pa
pe
r 
if
ne
ed
ed
Higher than CDSS
Same as CDSS 
Lower than CDSS
Longer than CDSS
Same as CDSS
Shorter than CDSS
Diagnosis
Target range for INR
Actual INR measured
3.
00
 
or
 
m
or
e
0.
50
1.
00
1.
50
2.
00
2.
50
1–
2
3–
4
5–
6
M
or
e
Pa
ti
en
t 
ID
cognitive function, might be recalled more often. The
workshop reinforced the appreciation of the nurses of
the opportunity to discuss experiences in a sympathetic
group, and share ideas of how to consult effectively
and where the boundaries of acceptable variation from
the CDSS guidance might lie. Their intention was to
continue this group as a mechanism for long-term
support, and within which to externalise the experience
gained in practice.
Discussion
The action research identified tension associated with
overriding the CDSS recommendations as the greatest
problem in implementing this system. This was entirely
unpredicted. The nurses’ training, whilst providing
the necessary biomedical and technical knowledge,
specified how INR monitoring is usually performed
in the haematology clinic, rather than discussing how
it could be incorporated into their everyday practice.
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Figure 2 Variation in warfarin dose from the recommendation of the CDSS (n=165)
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Figure 3 Variation in recall interval from the recommendation of the CDSS (n=165)
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The nurses’ pragmatic response was to practise
cautiously.
The study has implications for those looking to
introduce CDSS into clinical practice. Although a tech-
nical process, the implementation was also a social
process – nurses were taking responsibility for
patients taking a medication with potentially serious
adverse effects.3 They were doing this within their
individual general practices, with day-to-day support
coming from a doctor within that practice team
rather than from their peer group. A shortcoming 
of the implementation was the lack of a nursing group
to provide mutual support, share knowledge and
accelerate learning.13
The number of nurses involved in the study dimin-
ished towards the end, limiting its completeness.
Of the original 18 nurses involved: four left their job;
12 out of the remaining 14 attended the second
workshop and 11 of these completed the audit; two
went on leave, and one was absent, leaving eight who
attended the final workshop. No causal link could be
found between those who left their posts and running
the clinic, though this high rate of job turnover is
unusual in practice nursing. Although there was
variation from the CDSS recommendations, there
were no reported cases of over- or under-dosing with
warfarin during the period of the study. The variation
from the dose suggested by the software was 35%,
which is higher than the 25% found by Vadher et al
when they studied nurses using CDSS.8 However, it is
less than the 43% gap found when doctors’ decisions
were compared with that suggested by the CDSS.
Robinson et al suggest that ‘cognitive dissonance’ –
occurring when the CDSS clashes with the intuition
of the clinician – provides insight and a mechanism
for learning in the consultation.14 Our findings suggest
that the educational benefit of CDSS in consultation
is limited – and that the creation of a group, a com-
munity of practice, within which knowledge can be
socialised and shared, was more effective.15,16 Primary
care organisations should consider using accredited
anticoagulant training courses, which might have
provided more opportunities for networking with
other practitioners.17
The socio-technical literature provides further
insights. Goorman and Berg point out the danger of
modelling new technologies based on an idealised
model of how work should be done rather than recog-
nising that although real life often appears complex,
healthcare work is usually pragmatic.18 ‘Practical
rationality’, as they would term the cautious response
of the nurses, ‘can only be overlooked at a high price
(i.e. system failure)’.19 Berg’s alternative approach to
implementation would have been to recognise that
technological implementation involves transformation
of organisations and individuals, and it always has
unforeseen consequences.20
Further research is needed to define where the
boundary lies between acceptable variation from 
the CDSS recommendations and what represents
dangerous practice. A greater understanding is needed
of the value of providing groups for mutual support
and for developing a shared body of knowledge about
how to implement near patient monitoring. The cost-
effectiveness of different ways of providing anticoagulant
services needs to be compared. Nurse-run general
practice clinics need to be compared from the per-
spectives of case-mix as well as control, with patients
self-monitoring at home, and hospital clinics.21
Conclusions
Studying dosage of warfarin and interval to the next
review appointment assisted by CDSS was expected to
be a simple area of biomedicine: it was supposed that
what traditionally took place in hospital clinics could
be modelled, and using near patient testing devices
and CDSS could be readily translated into the
primary care setting. However, the nurses using CDSS
experienced cognitive dissonance. In these circumstances,
the nurses felt stressed and most often responded by
being cautious – reducing the dose or recall interval –
though variation occurred in both directions. The study
demonstrates that technological solutions modelled
on hospital practice may have unforeseen consequences
and be hard to implement in primary care.
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